These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 27087457)

  • 41. ["Fatigue" in multiple sclerosis. Development and and validation of the "Würzburger Fatigue Inventory for MS"].
    Flachenecker P; Müller G; König H; Meissner H; Toyka KV; Rieckmann P
    Nervenarzt; 2006 Feb; 77(2):165-6, 168-70, 172-4. PubMed ID: 16160812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Improving fatigue in multiple sclerosis by smartphone-supported energy management: The MS TeleCoach feasibility study.
    D'hooghe M; Van Gassen G; Kos D; Bouquiaux O; Cambron M; Decoo D; Lysandropoulos A; Van Wijmeersch B; Willekens B; Penner IK; Nagels G
    Mult Scler Relat Disord; 2018 May; 22():90-96. PubMed ID: 29649789
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined exercise training reduces fatigue and modulates the cytokine profile of T-cells from multiple sclerosis patients in response to neuromediators.
    Alvarenga-Filho H; Sacramento PM; Ferreira TB; Hygino J; Abreu JEC; Carvalho SR; Wing AC; Alvarenga RMP; Bento CAM
    J Neuroimmunol; 2016 Apr; 293():91-99. PubMed ID: 27049568
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Management options in multiple sclerosis-associated fatigue.
    Amato MP; Portaccio E
    Expert Opin Pharmacother; 2012 Feb; 13(2):207-16. PubMed ID: 22220738
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Fatigue and multiple sclerosis.
    Béthoux F
    Ann Readapt Med Phys; 2006 Jul; 49(6):265-71, 355-60. PubMed ID: 16757056
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
    Nourbakhsh B; Revirajan N; Waubant E
    Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Origin of fatigue in multiple sclerosis: review of the literature.
    Kos D; Kerckhofs E; Nagels G; D'hooghe MB; Ilsbroukx S
    Neurorehabil Neural Repair; 2008; 22(1):91-100. PubMed ID: 17409388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Does amantadine have favourable effects on fatigue in Persian patients suffering from multiple sclerosis?
    Ashtari F; Fatehi F; Shaygannejad V; Chitsaz A
    Neurol Neurochir Pol; 2009; 43(5):428-32. PubMed ID: 20054744
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A randomised controlled trial of an exercise plus behaviour change intervention in people with multiple sclerosis: the step it up study protocol.
    Coote S; Gallagher S; Msetfi R; Larkin A; Newell J; Motl RW; Hayes S
    BMC Neurol; 2014 Dec; 14():241. PubMed ID: 25528262
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fatigue in multiple sclerosis: definition, pathophysiology and treatment.
    Krupp LB
    CNS Drugs; 2003; 17(4):225-34. PubMed ID: 12665396
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Fatigue in multiple sclerosis].
    Dworzańska E; Mitosek-Szewczyk K; Stelmasiak Z
    Neurol Neurochir Pol; 2009; 43(1):71-6. PubMed ID: 19353446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Moderators of Treatment Outcomes After Telehealth Self-Management and Education in Adults With Multiple Sclerosis: A Secondary Analysis of a Randomized Controlled Trial.
    Ehde DM; Arewasikporn A; Alschuler KN; Hughes AJ; Turner AP
    Arch Phys Med Rehabil; 2018 Jul; 99(7):1265-1272. PubMed ID: 29337024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Minimally important difference of the fatigue severity scale and modified fatigue impact scale in people with multiple sclerosis.
    Rooney S; McFadyen DA; Wood DL; Moffat DF; Paul PL
    Mult Scler Relat Disord; 2019 Oct; 35():158-163. PubMed ID: 31400557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fatigue in multiple sclerosis.
    Krupp LB; Christodoulou C
    Curr Neurol Neurosci Rep; 2001 May; 1(3):294-8. PubMed ID: 11898532
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Resting-state functional connectivity networks associated with fatigue in multiple sclerosis with early age onset.
    Stefancin P; Govindarajan ST; Krupp L; Charvet L; Duong TQ
    Mult Scler Relat Disord; 2019 Jun; 31():101-105. PubMed ID: 30954931
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Exercise Training for Multiple Sclerosis: A Narrative Review of History, Benefits, Safety, Guidelines, and Promotion.
    Learmonth YC; Motl RW
    Int J Environ Res Public Health; 2021 Dec; 18(24):. PubMed ID: 34948854
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New Strategies for Rehabilitation and Pharmacological Treatment of Fatigue Syndrome in Multiple Sclerosis.
    Zielińska-Nowak E; Włodarczyk L; Kostka J; Miller E
    J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33171768
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Management of fatigue in persons with multiple sclerosis.
    Khan F; Amatya B; Galea M
    Front Neurol; 2014; 5():177. PubMed ID: 25309504
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Overview of the Current Pathophysiology of Fatigue in Multiple Sclerosis, Its Diagnosis and Treatment Options - Review Article.
    Zimek D; Miklusova M; Mares J
    Neuropsychiatr Dis Treat; 2023; 19():2485-2497. PubMed ID: 38029042
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.